If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
HEMATOLOGY
EMJ Hematol. 2019 Suppl 1 • europeanmedical-journal.com
INSIDE
Expectations and Experience:
Optimising Efficacy and
Maintaining Quality of Life
in Follicular Lymphoma
Expectations and Experience: Optimising
Efficacy and Maintaining Quality of Life
in Follicular Lymphoma
This satellite symposium took place on 14th June 2018,
as part of the 23rd European Hematology Association
(EHA) Annual Congress in Stockholm, Sweden
Chairpeople: Judith Trotman1 and Gilles Salles2
Speakers: Gilles Salles,2 John Seymour,3 Judith Trotman,1 Ruth Pettengell,4 Guy
Bouguet5
1. Concord Repatriation General Hospital, University of Sydney, Sydney, Australia
2. Hospices Civils de Lyon, Université de Lyon, Lyon, France
3. Peter MacCallum Cancer Centre, Royal Melbourne Hospital; University of
HEMATOLOGY EMJ Hematol. 2019 Suppl 1 • europeanme
Expectations and Experience: Optimising Efficacy
Prof Seymour presented data showing that two-thir
are effective second-line therapies for FL, death
GALLIUM: PFS was significantly improved w PFS af
Recent Developments in Characterising High-Risk
and low 23 gene scores achieve PFS at 10 years.
Other potential prognostic parameters include tot
Patient survey, with 6,600 responden
Clinical considerations around treatment
follicular lymphoma. Abstract 7500. ASCO Meeting,
37. Lymphoma Coalition. Follicular